comprimé gastro-resistant

DRUG3 trials

Sponsors

Centre Hospitalier Universitaire De Caen Normandie, Centre Hospitalier Universitaire De Dijon, Centre Hospitalier Regional Et Universitaire De Brest

Conditions

All adult patients with successful transfemoral trans-aortic valve implantation (TAVI ) for symptomatic aortic stenosis (AS) with no other indication for long term antiplatelet or anticoagulant therapyPhiladelphia-negative myeloproliferative neoplasms are frequent and chronic myeloid malignancies including Polycythemia Vera (PV)Primary Myelofibrosis (PMF) and Prefibrotic myelofibrosis (PreMF).acute pneumoniaessential thrombocythemia (ET)

Phase 2

Short versus long antiplatelet therapy after TAVI

RecruitingCTIS2023-508208-40-00

Centre Hospitalier Universitaire De Caen NormandieAll adult patients with successful transfemoral trans-aortic valve implantation (TAVI ) for symptomatic aortic stenosis (AS) with no other indication for long term antiplatelet or anticoagulant therapy

Start: 2024-11-21Target: 1400Updated: 2025-05-07

Apixaban/rivaroxaban Versus Aspirin for primary prevention of thrombo-embolic complications in JAK2V617F-positive myeloproliferative neoplasms

Not yet recruitingCTIS2024-515362-13-00

Centre Hospitalier Regional Et Universitaire De Brestessential thrombocythemia (ET), Philadelphia-negative myeloproliferative neoplasms are frequent and chronic myeloid malignancies including Polycythemia Vera (PV), Primary Myelofibrosis (PMF) and Prefibrotic myelofibrosis (PreMF).

Target: 1008Updated: 2025-07-11

Phase 3

ASPAPY - Aspirin in acute pneumonia in the elderly: a multicenter, double-blind, randomized, placebo-controlled trial

Not yet recruitingCTIS2024-510811-32-00

Centre Hospitalier Universitaire De Dijonacute pneumonia

Target: 600Updated: 2025-09-10

Related Papers

ASPirin for Acute Pneumonia in the elderlY (ASPAPY): protocol of a multicentre randomised double-blind placebo-controlled trial

BMJ Open2025-05-01